Dr. Amit Bhalla, MD

• Conferred with existing and potential customers to assess requirements and propose optimal solutions.

• Headed Medico-marketing and Clinical
  trial/Regulatory function teams. Leading a team of 7
  personnel, organized and prioritized work to
  complete assignments in a timely, efficient manner.
  Experience in medicomarketing of first in the World
  Nasal Methylcobalamin spray (Naso B12)
  formulation, and leading pain brands of Dynapar
  and Dynapar QPS.
  
• Defined success by goal achievement and continuous improvement. Projects like novel sublingual formulations of NSAIDs.
  
• KOL networking across specialities like Gastros, Orthos, and SEC members of DCGI
  
• Pharmacovigilance Officer in-charge.

• Medical Advisor for Oncology Divisions like Ingenia and Oncosciences, and other business teams- Corza, Fortiza, Heptiza, Therapy area covering Gastroenterology and Oncology.
• Scientific affairs of Oncology monoclonal antibodies like Vivitra
  (trastuzumab biosimilar) and Bryxta (bevacizumab
  biosimilar) related activities.
• Major products that I developed over these 9 years are Oncology products like Clofarabine, Plerixafor, Bevacizumab, Trastuzumab biosimilars.
• Spearheaded Vivitra phase IV study program (Registry), including protocol, CRF, ICF development and guidance to MSL team on implementation of the project. Interrim dataanalysis, its presentation on various fora of advisory boards.
• Mentoring roles: Directly managed a team of 5 MSLs across major metro cities in India.
• Spearheaded clinical trial of Probiotics.
• Probiotics paper presented as poster in American College of Clinical Pharmacology 2011 annual meeting held in Chicago, IL, United States.
• GERD taskforce was a specialty focused study to look at frequency of various grades of esophagitis in patients with heartburn in India, in Gastroenterology which was my responsibility. For this, created a massive coordination platform for top 30 gastroenterologists of the country in partnership Indian Society of Gastroenterology (ISG) as well as global icons- Dr Prateek Sharma, Dr Shobna Bhatia, Dr KT Shenoy, Dr Uday Ghoshal, Dr Usha, Dr Ajit Sood, Dr. Jayanthi, to name a few.
• Working closely with Indian Society of Gastroenterology (ISG) identified taskforce to create consensus on GERD management. Internationally renowned gastros like Dr Nimish Vakil, Dr Prateek Sharma were engaged in company specific endeavors.
• Clinical Phase IV studies for identified brands in gastro and multispecialty divisions.
• Coordination with faculty for newly instituted new web based platforms of symposia like Masterclass.
• Responsible for the co-ordination of Medical Affairs activities like Science Advisory boards & Symposia.
• Others drugs launced/developed like Exemptia (Adalimumab), SoviHep (Sofosbuvir), Acopep (acotiamide), Deca Durabolin, Klinz (clindamycin), Iladac (ilaprazole), Revaprazan.
• Apart from these, was responsible for science behind Pantodac (pantoprazole), Pantodac DSR. The brand was maintained at a pinnacle position amongst PPIs.
• Conducted CME programs as a speaker for Brands like Vivitra, Duonem (faropenem), IBSet (ramosetron), Ciboz (rifaximin), Acopep at multiple locations across India with a measurable business gain for the targeted brands. 25 such CMEs with close to 1000 doctors' audiences (Oncologists, Gastros, Physicians, GPs, Orthopedics, Urologists, Oncologists)
• Medical Lead for Vaccines like Flu vaccine Vaxiflu-S & antirabies vaccine Vaxirab
• Provide timely and informative responses to scientific
  queries from external customers and internal
  partners, which accurately reflect scientific data.
• Medical Lead for therapies from acute multispecialty brands like antibiotics & pain portfolio, to specialty driven PPIs like Pantodac, superspecialty brands Exemptia, SoviHep and MABs, as also networking with the top of the apex doctors (KOLs) of ISG.

• Responsible for Chronic care business CV Life division dedicated to Statins and antihypertensive/antidiabetic portfolio, launched many new products.
• Rosuvastatin phase IV trial.
  Rosuvas (rosuvastatin) was adjudicated as best promoted brand in its category, its line extensions, Teleact
  (Telmisartan) extensions, olvance (Olmesartan).
  Olvamlo (Olmesartan and amlodipine fixed dose
  combination) inputs were appreciated by organization for
  the medical insight and support.
  
• Conducting CME. Conduct regular CME's all across
  India and try to develop and train local speakers. •
  International Symposia. Scientific support for
  International symposia single handedly for Diabetes,
  Hypertension, and Dyslipidemia. o DIABETICA-09
  (Diabetologists): Dr. Wangnoo, and Dr. Shashank
  Joshi o HDL INTERNATIONAL SYMPOSIA-09
  (Physicians) held at Langkawi Malaysia.
  
• Pharmacovigilance. Trained field force all across
  India in pharmacovigilance and ADR reporting.
  Responsible link between the doctor's complaint,
  field force, and the PV department.

• Medical Advisor leading a team of 4 members medical department, for Prima-Vista divisions.
• This was a leadership role for first time in medico marketing domain.

• Medical Advisor for acute therapy business Maxima division.
• Medicomarketing for Algest, Symbiotik XL, Zycin, Fytobact XL, ATT therapy, Nodon T, Aciloc, Immuvac.
• Clinical development studies, Phase III for Mw (IMMUVAC)
• Extensive Fieldwork

• Worked as Principal Investigator for BE studies.

• Teaching Pharmacology to medical undergraduates program MBBS at DMC, Ludhiana.

• Prior to MD, worked as GP in private clinic.

• Junior Resident in Orthopedics department.
• Trained hands-on inserting Crutchfield tongs traction for skull traction and Tibial traction in Emergency department.

• General duty Medical officer.

• Junior Resident in Surgery department.
• Burns patient's dressings, assisting in surgeries like Lap Cholecystectomy, Open Cholecystectomy, appendectomy, Ileostomy procedures.

Active participation as physician in National Pulse Polio immunization drive for 2 rounds.